When participants look more like our neighbors, better results are within reach.

Get your patient journey guide to help refine recruitment strategies and overcome enrollment barriers with patient insights.
We’re giving our life science partners access to clinical research sites in underrepresented communities with 20 fully operational sites across 8 states. See one of our newest sites in Malden, MA.
Watch the video
Walgreens delivers clinical trial experiences patients trust by bringing equitable connections, enhanced patient access, and improved clinical outcomes within reach.
Walgreens study exceeds goals, with 57% Black and Hispanic participants in weight health study.
Read the case study
Recruitment
Walgreens exceeds norovirus study’s goals by over 30%, on-time, and under budget.
Read more
Patient Survey
200 surveys collected in under 4 weeks from a difficult to reach patient audience.
Read more
Enrollment
Our community-centered approach enrolled over 60% of a study’s total participants.
Read more
Outreach
Recruitment from our trusted name increased representation in patient enrollment.
Read more
Speed-to-trial
Our start-up protocol delivered unparalleled recruitment speed.
Read more
Increasing Representation
We leveraged real-world insights to deliver 21% Hispanic patient referrals.
Read more
Recruitment and Retention
Our recruitment efforts saw twice the amount of African American and Hispanic trial participation than usual.
Read more
Recruitment
Walgreens helped exceed study recruitment target by 55% in the first month.
Read more
Real world evidence
Reach a more diverse patient population faster with more impactful data.
Read more
Conduct
Improve clinical trial study conduct with comprehensive support from Walgreens.
Read more
Recruitment
Accelerate study recruitment by partnering with the trusted Walgreens name.
Read more
Outreach
Walgreens can help improve trial success and reach patients you never have before.
Read more
May 2025
Exploring barriers to treatment with biologics vs. non-biologics for plaque psoriasis.
Read more
May 2025
Using retrospective pharmacy data to uncover trends in GLP-1s which may inform intervention strategies.
Read more
April 2025
Assessing psychosocial and structural barriers by those prescribed initial HIV pre-exposure prophylaxis in retail pharmacies.
Read more
May 2024
Using pharmacy data to assess trends and vaccine uptake in a nationally representative population.
Read more
April 2024
Examining challenges in PrEP pickups and barriers to achieve Ending the HIV Epidemic initiative goals.
Read more
April 2024
Identifying flu activity and virus type from customers seeking respiratory pathogen testing.
Read more
April 2024
Analyzing pharmacy data to identify patterns in SARS-CoV-2, flu and RSV vaccine administration.
Read more